Literature DB >> 8426445

Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link?

D Ames, W C Wirshing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8426445

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin.

Authors:  Alison M Haddow; Dawn Harris; Martin Wilson; Hannah Logie
Journal:  BMJ       Date:  2004-12-04

Review 2.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 3.  Neuroleptic malignant syndrome.

Authors:  P F Buckley; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

Review 4.  Neuroleptic malignant syndrome in the acquired immunodeficiency syndrome.

Authors:  J L Hernández; L Palacios-Araus; S Echevarría; A Herrán; J F Campo; J A Riancho
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

Review 5.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 6.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

7.  Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

Authors:  J E Malberg; L S Seiden
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

Review 8.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

9.  A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity.

Authors:  J R Coore
Journal:  J R Soc Med       Date:  1996-01       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.